SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): August 12, 2003
ESCO TECHNOLOGIES INC.
Missouri | 1-10596 | 43-1554045 | ||
(State or Other | (Commission | (I.R.S. Employer | ||
Jurisdiction of Incorporation) | File Number) | Identification No.) |
8888 Ladue Road, Suite 200, St. Louis, Missouri | 63124-2056 | |
(Address of Principal Executive Offices) | (Zip Code) |
Registrants telephone number, including area code: 314-213-7200
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS
(c) | Exhibits |
Exhibit No | Description of Exhibit | |
99.1 | Press Release dated August 12, 2003 |
ITEM 9. REGULATION FD DISCLOSURE
Operations and Financial Information Furnished
On August 12, 2003, the Company issued a press release announcing its fiscal third quarter 2003 financial and operating results. This press release is furnished as Exhibit 99.1, and incorporated herein by reference.
In addition, the Company announced in a press release issued on July 22, 2003 that a webcast of a third quarter conference call will be held on August 12, 2003 at 9:30 a.m., central time.
The press release furnished herewith will be posted to the Companys website located at http://www.escotechnologies.com and can be viewed through the Investor Relations page of the website under the tab Press Releases, although the Company reserves the right to discontinue that availability at any time.
ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION
Operations and Financial Information Furnished
On August 12, 2003, the Company issued a press release (Exhibit 99.1 to this report) announcing its fiscal third quarter 2003 financial and operating results. The Company previously announced that a webcast of a third quarter conference call will be held on August 12, 2003, and the press release will be posted to the Companys website. See Item 9, Regulation FD Disclosure, above.
Non-GAAP Financial Measures
The press release furnished herewith contains financial measures and financial terms not calculated in accordance with generally accepted accounting principles in the United States of America (GAAP) in order to provide investors and management with an alternative method for assessing the Companys operating results in a manner that is focused on the performance of the Companys ongoing operations. The Company has provided definitions below for the non-GAAP financial measures utilized in the press release, together with an explanation of why management uses these measures, and why management believes that these non-GAAP financial measures are useful to investors. The press release uses the non-GAAP financial measures of adjusted sales, net earnings, earnings per share, and results of operations, operational sales, net earnings, earnings per share, and results of operations, EBIT from continuing operations, free cash flow, Filtration segment operational net sales and EBIT, and EBITDA from continuing operations.
The Company defines adjusted sales, net sales, net earnings, earnings per share, results of operations as sales, net sales, net earnings, earnings per share, and results of operations in accordance with GAAP except for the exclusion of (i) asset impairment charges and severance charges related to the shutdown of the Filtration segment Puerto Rico facility and the move and restructuring of the Test segment UK operations, (ii) a one-time charge resulting from the termination of a Manufacturing and Supply Agreement (MSA) with Whatman HemaSure Inc., (iii) costs resulting from a Management Transition Agreement between the Company and its former Chairman (MTA), (iv) a gain from the settlement of certain patent
litigation, and (v) a gain on the sale of Rantec Power Systems, Inc., which has been divested and is shown as discontinued operations. The Company defines operational sales, net sales, net earnings, earnings per share, results of operations as adjusted sales, net earnings, earnings per share, and results of operations, excluding revenues, costs and expenses relating to the Filtration segment Microfiltration and Separations businesses (MicroSep), which will be presented as discontinued operations beginning in the fourth quarter of fiscal 2003. The Companys management uses these adjusted and operational results in evaluating the measures of continuing operations of the Company and believes that this information provides investors with additional insight into the period over period financial performance of the Company. The items excluded will not have a material effect on the Companys results of operations after the fourth quarter ending September 30, 2003.
The Company defines EBIT from continuing operations as earnings before interest and taxes. The Companys management evaluates the performance of its operating segments based on EBIT from continuing operations and believes that EBIT from continuing operations is useful to investors to demonstrate the operational profitability of the Companys business segments by excluding interest and taxes, which are generally accounted for across the entire Company on a consolidated basis. EBIT from continuing operations is also one of the measures used by management in determining resource allocations within the Company and incentive compensation.
The Company defines Free cash flow as Net cash provided by operating activitiescontinuing operations less Capital expenditurescontinuing operations. The Companys management believes that free cash flow is useful to investors and management as a supplemental financial measurement in the evaluation of the Companys business and believes that free cash flow may provide additional information with respect to the Companys ability to meet its future debt service, capital expenditures and working capital requirements. Free cash flow can also be reinvested in the Company for future growth.
The Company defines Filtration segment operational net sales and EBIT as segment net sales and EBIT, excluding the costs related to the shutdown of the Puerto Rico facility, the gain from the settlement of certain patent litigation, revenue, costs and expenses relating to MicroSep businesses, and the MSA charge.
The Company defines EBITDA as earnings before interest, taxes, depreciation and amortization. The Companys management uses EBITDA as a supplemental financial measurement in the evaluation of the Companys business and believes that EBITDA may provide additional information with respect to the Companys ability to meet its future debt service, capital expenditures and working capital requirements.
The presentation of the information described above is intended to supplement investors understanding of the Companys operating performance. The Companys non-GAAP financial measures may not be comparable to other companies non-GAAP financial performance measures. Furthermore, these measures are not intended to replace net earnings, cash flows, financial position, or comprehensive income (loss), as determined in accordance with GAAP.
Other Matters
The information contained in this report, including Exhibit 99.1, shall not be deemed to be filed for the purposes of Section 18 of the Securities Exchange Act of 1934 as amended (Exchange Act) or otherwise subject to the liabilities of that section, unless the Company specifically incorporates it by reference in a document filed under the Securities Act of 1933 as amended or the Exchange Act.
Statements in this report, including Exhibit 99.1, regarding the Companys ability to negotiate a successful settlement and/or enforce the terms of the MSA, results of future closures, consolidations, relocations, divestitures and real estate sales, the associated costs and resulting savings to be achieved, future fiscal 2003 revenues, gains/charges and earnings and other written or oral statements which are not strictly historical are forward-looking statements within the meaning of the safe harbor provisions of the federal securities laws. Investors are cautioned that such statements are only predictions, and speak only as of the date of this report. The Companys actual results in the future may differ materially from those
projected in the forward-looking statements due to risks and uncertainties that exist in the Companys operations and business environment including, but not limited to: the timing and terms of the planned divestiture of the MicroSep businesses; further weakening of economic conditions in served markets; changes in customer demands or customer insolvencies; competition; intellectual property rights; the Companys successful exploitation of acquired intellectual property rights; the performance of discontinued operations prior to completing the divestiture; successful execution of planned facility closures, sales, consolidations and relocations with regard to the Companys Puerto Rico facility and U.K. facility; the impact of FASB Interpretation No. 46; consolidation of internal operations; integration of recently acquired businesses; delivery delays or defaults by customers; termination for convenience of customer contracts; the Companys enforcement of its contractual rights under the MSA; timing and magnitude of future contract awards; performance issues with key suppliers and subcontractors; collective bargaining and labor disputes; changes in laws and regulations including changes in accounting standards and taxation requirements; litigation uncertainly; and the Companys successful execution of internal operating plans.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ESCO TECHNOLOGIES INC. | ||||||
Dated: August 12, 2003 | By: | /s/ G.E. Muenster | ||||
G.E. Muenster | ||||||
Vice President and | ||||||
Chief Financial Officer |
EXHIBIT INDEX
Exhibit No. | Description of Exhibit | |
99.1 | Press release dated August 12, 2003 |